{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:49:48Z","timestamp":1782805788865,"version":"3.54.5"},"reference-count":55,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Piano per la Ricerca 2016-2018 - FIR 2018-2020 - F.D.R.","award":["Piano per la Ricerca 2016-2018 - FIR 2018-2020"],"award-info":[{"award-number":["Piano per la Ricerca 2016-2018 - FIR 2018-2020"]}]},{"name":"PON AIM R&amp;I 2014-2020 - N.V.","award":["E66C18001240007"],"award-info":[{"award-number":["E66C18001240007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Multiple myeloma (MM) is a clonal B-cell malignancy characterized by an accumulation of plasma cells (PC) in the bone marrow (BM), leading to bone loss and BM failure. Osteolytic bone disease is a common manifestation observed in MM patients and represents the most severe cause of morbidity, leading to progressive skeletal damage and disabilities. Pathogenetic mechanisms of MM bone disease are closely linked to PCs and osteoclast (OCs) hyperactivity, coupled with defective osteoblasts (OBs) function that is unable to counteract bone resorption. The aim of the present study was to investigate the effects of Ixazomib, a third-generation proteasome inhibitor, on osteoclastogenesis and osteogenic differentiation. We found that Ixazomib was able to reduce differentiation of human monocytes into OCs and to inhibit the expression of OC markers when added to the OC medium. Concurrently, Ixazomib was able to stimulate osteogenic differentiation of human mesenchymal stromal cells (MSCs), increasing osteogenic markers, either alone or in combination with the osteogenic medium. Given the key role of Sonic Hedgehog (SHH) signaling in bone homeostasis, we further investigated Ixazomib-induced SHH pathway activation. This set of experiments showed that Ixazomib, but not Bortezomib, was able to bind the Smoothened (SMO) receptor leading to nuclear translocation of GLI1 in human MSCs. Moreover, we demonstrated that PCs act as GLI1 suppressors on MSCs, thus reducing the potential of MSCs to differentiate in OBs. In conclusion, our data demonstrated that Ixazomib regulates bone remodeling by decreasing osteoclastogenesis and prompting osteoblast differentiation via the canonical SHH signaling pathway activation, thus, representing a promising therapeutic option to improve the complex pathological condition of MM patients.<\/jats:p>","DOI":"10.3390\/cancers12020323","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T01:25:51Z","timestamp":1580693151000},"page":"323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ixazomib Improves Bone Remodeling and Counteracts Sonic Hedgehog Signaling Inhibition Mediated by Myeloma Cells"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4416-8556","authenticated-orcid":false,"given":"Daniele","family":"Tibullo","sequence":"first","affiliation":[{"name":"Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Longo","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5934-3962","authenticated-orcid":false,"given":"Nunzio","family":"Vicario","sequence":"additional","affiliation":[{"name":"Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-4433","authenticated-orcid":false,"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of General Surgery and Medical-Surgical Specialties, A.O.U. \u201cPoliclinico-Vittorio Emanuele\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-6302","authenticated-orcid":false,"given":"Alessandro","family":"Barbato","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of General Surgery and Medical-Surgical Specialties, A.O.U. \u201cPoliclinico-Vittorio Emanuele\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1837-9325","authenticated-orcid":false,"given":"Michelino","family":"Di Rosa","sequence":"additional","affiliation":[{"name":"Section of Human Anatomy, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-0662","authenticated-orcid":false,"given":"Ignazio","family":"Barbagallo","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Drug Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelina Daniela","family":"Anfuso","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Lupo","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8067-697X","authenticated-orcid":false,"given":"Rosario","family":"Gulino","sequence":"additional","affiliation":[{"name":"Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-4696","authenticated-orcid":false,"given":"Rosalba","family":"Parenti","sequence":"additional","affiliation":[{"name":"Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-2183","authenticated-orcid":false,"given":"Giovanni","family":"Li Volti","sequence":"additional","affiliation":[{"name":"Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-6319","authenticated-orcid":false,"given":"Giuseppe Alberto","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Section of Haematology, Department of Medical and Surgical Sciences and Advanced Technologies \u201cG.F. Ingrassia\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of General Surgery and Medical-Surgical Specialties, A.O.U. \u201cPoliclinico-Vittorio Emanuele\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Giallongo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of General Surgery and Medical-Surgical Specialties, A.O.U. \u201cPoliclinico-Vittorio Emanuele\u201d, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Terpos, E., Christoulas, D., Gavriatopoulou, M., and Dimopoulos, M.A. (2017). Mechanisms of bone destruction in multiple myeloma. Eur. J. Cancer Care, 26.","DOI":"10.1111\/ecc.12761"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1423-0127-21-10","article-title":"Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1\/2 and Akt activation","volume":"21","author":"Tsubaki","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","article-title":"Pathogenesis of bone disease in multiple myeloma: From bench to bedside","volume":"8","author":"Terpos","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.4081\/hr.2018.7401","article-title":"Bone-targeted agents in multiple myeloma","volume":"10","author":"Nishida","year":"2018","journal-title":"Hematol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3324\/haematol.2013.090977","article-title":"Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells","volume":"99","author":"Noll","year":"2014","journal-title":"Haematologica"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1937-6448(08)00602-3","article-title":"Role of proteasomes in cellular regulation","volume":"267","author":"Konstantinova","year":"2008","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2217\/imt.13.14","article-title":"Bortezomib for the treatment of previously untreated multiple myeloma","volume":"5","author":"Romano","year":"2013","journal-title":"Immunotherapy-UK"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bone.2014.01.005","article-title":"Determination of chitinases family during osteoclastogenesis","volume":"61","author":"Tibullo","year":"2014","journal-title":"Bone"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2005.05.098","article-title":"Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function","volume":"333","author":"Zavrski","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jcp.21787","article-title":"Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades","volume":"220","author":"Ang","year":"2009","journal-title":"J. Cell Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/sj.leu.2404806","article-title":"Bortezomib inhibits human osteoclastogenesis","volume":"21","author":"Krebbel","year":"2007","journal-title":"Leukemia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fphar.2015.00226","article-title":"Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells","volume":"6","author":"Tibullo","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2007-03-067710","article-title":"Myeloma bone disease and proteasome inhibition therapies","volume":"110","author":"Terpos","year":"2007","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17474086.2018.1518129","article-title":"Ixazomib: A novel drug for multiple myeloma","volume":"11","author":"Zanwar","year":"2018","journal-title":"Expert. Rev. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16918","DOI":"10.1074\/jbc.M115.663963","article-title":"The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway","volume":"290","author":"Yang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"172458","DOI":"10.1155\/2015\/172458","article-title":"Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling","volume":"2015","author":"Accardi","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: Paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","article-title":"Tissue repair and stem cell renewal in carcinogenesis","volume":"432","author":"Beachy","year":"2004","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcp.24823","article-title":"Novel hedgehog agonists promote osteoblast differentiation in mesenchymal stem cells","volume":"230","author":"Nakamura","year":"2015","journal-title":"J. Cell Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/jcb.23345","article-title":"Hedgehog signaling and osteoblast gene expression are regulated by purmorphamine in human mesenchymal stem cells","volume":"113","author":"Oliveira","year":"2012","journal-title":"J. Cell Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/excr.1999.4676","article-title":"Hedgehog signal transduction: From flies to vertebrates","volume":"253","author":"Murone","year":"1999","journal-title":"Exp. Cell Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nchembio0106-10","article-title":"Agonizing hedgehog","volume":"2","author":"Briscoe","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0092-8674(00)80094-X","article-title":"The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal","volume":"86","author":"Alcedo","year":"1996","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0092-8674(00)81374-4","article-title":"Dual roles for patched in sequestering and transducing Hedgehog","volume":"87","author":"Chen","year":"1996","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00441-014-1898-5","article-title":"Multi-lineage differentiation of human mesenchymal stromal cells on the biophysical microenvironment of cell-derived matrix","volume":"357","author":"Choi","year":"2014","journal-title":"Cell Tissue Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.7150\/ijms.6657","article-title":"CXCL12\/CXCR4 signal axis plays an important role in mediating bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells","volume":"10","author":"Liu","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/B978-0-12-394622-5.00022-5","article-title":"Sonic Hedgehog-mediated synergistic effects guiding angiogenesis and osteogenesis","volume":"88","author":"Fuchs","year":"2012","journal-title":"Vitam. Horm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ijos.2015.14","article-title":"The Hedgehog signalling pathway in bone formation","volume":"7","author":"Yang","year":"2015","journal-title":"Int. J. Oral Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ydbio.2018.03.005","article-title":"Epidermal regulation of bone morphogenesis through the development and regeneration of osteoblasts in the zebrafish scale","volume":"437","author":"Iwasaki","year":"2018","journal-title":"Dev. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vicario, N., Bernstock, J.D., Spitale, F.M., Giallongo, C., Giunta, M.A.S., Li Volti, G., Gulisano, M., Leanza, G., Tibullo, D., and Parenti, R. (2019). Clobetasol Modulates Adult Neural Stem Cell Growth via Canonical Hedgehog Pathway Activation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081991"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","article-title":"Advances in the biology and treatment of bone disease in multiple myeloma","volume":"17","author":"Raje","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.2017.76.6402","article-title":"Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"36","author":"Anderson","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/ejh.12325","article-title":"Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed\/refractory myeloma patients","volume":"93","author":"Romano","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1078-0432.CCR-13-1657","article-title":"Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease","volume":"20","author":"Quwaider","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1091\/mbc.e17-02-0096","article-title":"Ixazomib enhances parathyroid hormone-induced beta-catenin\/T-cell factor signaling by dissociating beta-catenin from the parathyroid hormone receptor","volume":"28","author":"Yang","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2008-08-174300","article-title":"Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin\/TCF signaling","volume":"113","author":"Qiang","year":"2009","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hu, B., Chen, Y., Usmani, S.Z., Ye, S., Qiang, W., Papanikolaou, X., Heuck, C.J., Yaccoby, S., Williams, B.O., and Van Rhee, F. (2013). Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074191"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.devcel.2008.02.003","article-title":"Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression","volume":"14","author":"Mak","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lv, W.T., Du, D.H., Gao, R.J., Yu, C.W., Jia, Y., Jia, Z.F., and Wang, C.J. (2019). Regulation of Hedgehog signaling Offers A Novel Perspective for Bone Homeostasis Disorder Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163981"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.reth.2014.10.002","article-title":"Signaling pathways regulating the specification and differentiation of the osteoblast lineage","volume":"1","author":"Hojo","year":"2015","journal-title":"Regen. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/cancers7030856","article-title":"The Role of Hedgehog Signaling in Tumor Induced Bone Disease","volume":"7","author":"Cannonier","year":"2015","journal-title":"Cancers"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2014-03-557298","article-title":"A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance","volume":"124","author":"Liu","year":"2014","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Singh, B.N., Fu, J., Srivastava, R.K., and Shankar, S. (2011). Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: Molecular mechanisms. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027306"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0301-472X(02)00864-0","article-title":"Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow","volume":"30","author":"Martin","year":"2002","journal-title":"Exp. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","article-title":"Characterization of cells with osteogenic potential from human marrow","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/10428194.2018.1493727","article-title":"Targeting the cross-talk between the hedgehog and NF-kappaB signaling pathways in multiple myeloma","volume":"60","author":"Cai","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13287-017-0653-8","article-title":"Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton\u2019s jelly-derived mesenchymal stem cells (WJ-MSC)","volume":"8","author":"Zavala","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1038\/s41598-017-07672-0","article-title":"Human adipose-derived mesenchymal stem cells seeded into a collagen-hydroxyapatite scaffold promote bone augmentation after implantation in the mouse","volume":"7","author":"Calabrese","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Calabrese, G., Giuffrida, R., Fabbi, C., Figallo, E., Lo Furno, D., Gulino, R., Colarossi, C., Fullone, F., Giuffrida, R., and Parenti, R. (2016). Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151181"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1007\/s12035-019-1607-1","article-title":"Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain","volume":"56","author":"Vicario","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gulino, R., Vicario, N., Giunta, M.A.S., Spoto, G., Calabrese, G., Vecchio, M., Gulisano, M., Leanza, G., and Parenti, R. (2019). Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061500"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ygeno.2006.06.007","article-title":"Genomic profiling of cortical neurons following exposure to beta-amyloid","volume":"88","author":"Paratore","year":"2006","journal-title":"Genomics"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1038\/ncomms11040","article-title":"CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil","volume":"7","author":"Almqvist","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/2\/323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:53:09Z","timestamp":1760172789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/2\/323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["cancers12020323"],"URL":"https:\/\/doi.org\/10.3390\/cancers12020323","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}